{"id":"https://genegraph.clinicalgenome.org/r/2b020806-19bb-454c-ad48-8acff0be913bv1.1","type":"EvidenceStrengthAssertion","dc:description":"RDH12, Retinol Dehydrogenase 12, was first reported in relation to RDH12-related recessive retinopathy in patient described with Leber congenital amaurosis, LCA, in 2004 (Janeke et al., PMID: 15258582). Variants in RDH12 cause early-onset retinal degeneration leading to vision loss with variable severity. To capture the overlapping spectrum of clinical presentations linked to this gene, it is curated under the disease entity “inherited retinal degeneration”. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found there to be a difference in inheritance pattern phenotypic variability. Therefore, the curation will be split into autosomal recessive inherited retinal degeneration, which includes cases described with autosomal recessive LCA (OMIM: 612712) and autosomal dominant inherited retinal degeneration, which will include autosomal dominant retinitis pigmentosa (OMIM: 268000). The split curation for autosomal dominant condition will be curated separately. \nFifteen variants (12 missense, 2 nonsense, 1 frameshift) that have been reported in 11 probands in 2 publications (PMIDs: 15258582, 32014858) are included in this curation. [Additional essential genetic evidence description]. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be LOF. This gene-disease association is also supported animal models, expression studies and in vitro functional assays (PMIDs: 12226107, 16269441, 17032653).  Haesseler et al (12226107) demonstrates that RDH12 enzyme catalyzed the reduction of all-trans-retinal and its 9-cis-, 11-cis-, and 13-cis-retinal isomers in the presence of NADPH. While Thompson et al. (16269441) shows expression of the transcript localizes to the inner segments of rod and cone photoreceptors.  Genetic alterations in RDH12 result in significantly decreased enzymatic activity and reduced expression of the protein suggesting LOF.  Finally, animal models show photoreceptor degeneration in RDH12 knockouts.  In summary, there is definitive evidence to support the relationship between RDH12 and RDH12-related recessive retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Retinal GCEP on the meeting date March 3, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2b020806-19bb-454c-ad48-8acff0be913b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-07-12T13:09:15.982Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-03-03T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70cc19b-0097-4f82-9fc8-3c4167be6270_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70cc19b-0097-4f82-9fc8-3c4167be6270","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"839","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0f8e9d73-c792-425e-abb8-5b44d1e191fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.565C>T (p.Gln189Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252078"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000523","obo:HP_0000550","obo:HP_0000529","obo:HP_0007737","obo:HP_0000639","obo:HP_0000546"],"previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9101775c-f07a-453b-b4f2-b089d94a0b18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f8e9d73-c792-425e-abb8-5b44d1e191fe"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9101775c-f07a-453b-b4f2-b089d94a0b18","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9101775c-f07a-453b-b4f2-b089d94a0b18_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7019407a-832d-4117-8cba-2935c85f3326_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7019407a-832d-4117-8cba-2935c85f3326","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"33","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e71e0160-ccc2-415e-a902-474643c678db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.184C>T (p.Arg62Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252081"}},{"id":"https://genegraph.clinicalgenome.org/r/36b15910-743a-4fc6-abc8-6f3ace6dfec1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.146C>T (p.Thr49Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252080"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000662","obo:HP_0000546","obo:HP_0000529","obo:HP_0000550","obo:HP_0007737","obo:HP_0007843"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/47853635-0cae-4039-ad1a-40ef17f2cda6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/e71e0160-ccc2-415e-a902-474643c678db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/31babbcf-627a-475b-a417-5139e3901dfc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/36b15910-743a-4fc6-abc8-6f3ace6dfec1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/47853635-0cae-4039-ad1a-40ef17f2cda6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47853635-0cae-4039-ad1a-40ef17f2cda6_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/31babbcf-627a-475b-a417-5139e3901dfc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31babbcf-627a-475b-a417-5139e3901dfc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/39820933-a6ac-4c94-bb65-66d9e8298238_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39820933-a6ac-4c94-bb65-66d9e8298238","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","rdfs:label":"OGI519-1068","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7279e371-64ea-4a7f-b436-c6e1af72dc72","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.844T>G (p.Phe282Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7238826"}},{"id":"https://genegraph.clinicalgenome.org/r/0c5d84e7-e9ee-45c7-8f6f-97bf4e763baf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.701G>A (p.Arg234His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7238798"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000603","obo:HP_0007663","obo:HP_0000007","obo:HP_0000608"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c231ff4d-871b-4050-bc28-9a2438e3fabe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/7279e371-64ea-4a7f-b436-c6e1af72dc72"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3c31e802-9097-40aa-9c8c-4cabbd60d7b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c5d84e7-e9ee-45c7-8f6f-97bf4e763baf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/c231ff4d-871b-4050-bc28-9a2438e3fabe","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c231ff4d-871b-4050-bc28-9a2438e3fabe_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3c31e802-9097-40aa-9c8c-4cabbd60d7b0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c31e802-9097-40aa-9c8c-4cabbd60d7b0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3c31e802-9097-40aa-9c8c-4cabbd60d7b0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 16269441 Fig. 3. HPLC analysis of recombinant RDH12 catalytic activity in lysates from COS-7 cells transfected with RDH12 wild-type and missense variants show p.Arg234His has 44% activity of wild type protein.  ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/c6427459-25b5-4ff9-be2a-33909e632609_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6427459-25b5-4ff9-be2a-33909e632609","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"2_I-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.677A>G (p.Tyr226Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252077"}},"detectionMethod":"Affymetrix GeneChip Human Mapping 10K Array version Xba131 was used for genotyping in 10 affected and 9 unaffected carriers.  Critical interval of 1.53cM identified in LCA3 locus with candidate genes RDH11 and RDH12.  Mutation screening was carried out using Sanger sequencing of all exons in RDH12 and RDH11.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0000550","obo:HP_0000543","obo:HP_0000529","obo:HP_0007737","obo:HP_0000556","obo:HP_0007843","obo:HP_0000007"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bddeb0c0-3d9c-4fa1-850f-814ba1159cc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/bddeb0c0-3d9c-4fa1-850f-814ba1159cc7","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bddeb0c0-3d9c-4fa1-850f-814ba1159cc7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bddeb0c0-3d9c-4fa1-850f-814ba1159cc7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"COS7 cells transfected with variant were assayed for interconversion of all-trans retinal to all-trans retinol and displayed significantly reduced activity compared wild type cells.  Immunohistochemisty showed reduced levels of protein in cells lines transfected with variant construct versus wild type construct.  Indicating variant impacts protein levels which may reduce activity levels.  ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/affc5d59-fc55-496c-8791-5f08a7d0e25d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/affc5d59-fc55-496c-8791-5f08a7d0e25d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","rdfs:label":"OGI2933-4518","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/72b4a186-d8e2-4b9f-a7f9-d81ac7770b4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.440A>C (p.Asn147Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390150338"}},{"id":"https://genegraph.clinicalgenome.org/r/0c5d84e7-e9ee-45c7-8f6f-97bf4e763baf"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000529","obo:HP_0200070","obo:HP_0007663","obo:HP_0000007","obo:HP_0007401"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e9e4cf86-9ecf-498f-8b7c-df8f73c116b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c5d84e7-e9ee-45c7-8f6f-97bf4e763baf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9678819e-eff8-4cbb-88e2-83230f3b0449_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/72b4a186-d8e2-4b9f-a7f9-d81ac7770b4f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/9678819e-eff8-4cbb-88e2-83230f3b0449","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9678819e-eff8-4cbb-88e2-83230f3b0449_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e9e4cf86-9ecf-498f-8b7c-df8f73c116b0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9e4cf86-9ecf-498f-8b7c-df8f73c116b0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e9e4cf86-9ecf-498f-8b7c-df8f73c116b0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"16269441 Fig. 3 In vitro assays of recombinant protein activity in the presence of all- trans retinal and NADPH, 44% the activity level of wild-type was observed p.H234  ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/6b4a222b-1097-45ce-9ae4-1b9b72e8f898_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b4a222b-1097-45ce-9ae4-1b9b72e8f898","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","rdfs:label":"OGI3076-4666","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9457da81-f8ff-4644-bac2-cad930c95bdd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.697G>A (p.Val233Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390152927"}},{"id":"https://genegraph.clinicalgenome.org/r/a1cbdd00-d85d-4b77-af11-9f76b8bde103","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.619A>G (p.Asn207Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7238762"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000529","obo:HP_0000007","obo:HP_0000548","obo:HP_0000512","obo:HP_0000551","obo:HP_0000613"],"previousTesting":true,"previousTestingDescription":"NGS panel for Stargardt's Disease","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c4212803-5c5a-4d31-9c94-ad6b27b98165_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/9457da81-f8ff-4644-bac2-cad930c95bdd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/03c00a54-b29d-43ee-8781-c7dd70c3aa1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1cbdd00-d85d-4b77-af11-9f76b8bde103"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/c4212803-5c5a-4d31-9c94-ad6b27b98165","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4212803-5c5a-4d31-9c94-ad6b27b98165_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/03c00a54-b29d-43ee-8781-c7dd70c3aa1d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03c00a54-b29d-43ee-8781-c7dd70c3aa1d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f02a7ca0-ece0-44a6-a3ef-0fb401291f79_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f02a7ca0-ece0-44a6-a3ef-0fb401291f79","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"1_II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2"},"detectionMethod":"Affymetrix GeneChip Human Mapping 10K Array version Xba131 was used for genotyping in 10 affected and 9 unaffected carriers.  Critical interval of 1.53cM identified in LCA3 locus with candidate genes RDH11 and RDH12.  Mutation screening was carried out using Sanger sequencing of all exons in RDH12 and RDH11.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/44b1966c-c69e-4e5e-afac-d538c71a8a08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/44b1966c-c69e-4e5e-afac-d538c71a8a08","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44b1966c-c69e-4e5e-afac-d538c71a8a08_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/44b1966c-c69e-4e5e-afac-d538c71a8a08_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"COS7 cells transfected with variant were assayed for interconversion of all-trans retinal to all-trans retinol and displayed significantly reduced activity compared wild type cells.  Immunohistochemisty showed reduced levels of protein in cells lines transfected with variant construct versus wild type construct.  Indicating variant impacts protein levels which may reduce activity levels.  ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/554765f2-87ab-476c-8d3f-19451ddd494f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/554765f2-87ab-476c-8d3f-19451ddd494f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"3_II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2"},"detectionMethod":"Affymetrix GeneChip Human Mapping 10K Array version Xba131 was used for genotyping in 10 affected and 9 unaffected carriers.  Critical interval of 1.53cM identified in LCA3 locus with candidate genes RDH11 and RDH12.  Mutation screening was carried out using Sanger sequencing of all exons in RDH12 and RDH11.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0000550","obo:HP_0000556","obo:HP_0000543","obo:HP_0007737","obo:HP_0000007","obo:HP_0007843","obo:HP_0000529"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4416b697-d560-4dd6-b6d6-3d8c0a162ab2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a32e1fb-a2c6-48d8-8f0e-495835f51da2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/4416b697-d560-4dd6-b6d6-3d8c0a162ab2","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4416b697-d560-4dd6-b6d6-3d8c0a162ab2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4416b697-d560-4dd6-b6d6-3d8c0a162ab2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"COS7 cells transfected with variant were assayed for interconversion of all-trans retinal to all-trans retinol and displayed significantly reduced activity compared wild type cells.  Immunohistochemisty showed reduced levels of protein in cells lines transfected with variant construct versus wild type construct.  Indicating variant impacts protein levels which may reduce activity levels.  ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/20868ca8-71dc-43a9-8a31-2ed779891ce0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20868ca8-71dc-43a9-8a31-2ed779891ce0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","rdfs:label":"OGI3079-4672","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":17,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a1cbdd00-d85d-4b77-af11-9f76b8bde103"},{"id":"https://genegraph.clinicalgenome.org/r/62d8dd8d-2233-46e0-a5a1-34837051de82","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.185G>T (p.Arg62Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7238624"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000603","obo:HP_0007401","obo:HP_0007663","obo:HP_0000007"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/908a0a18-6e21-4f3d-aeda-c9a27a61a9e7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1cbdd00-d85d-4b77-af11-9f76b8bde103"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bdb21a90-7348-43fe-a0bd-56c300e76e7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/62d8dd8d-2233-46e0-a5a1-34837051de82"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/bdb21a90-7348-43fe-a0bd-56c300e76e7d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb21a90-7348-43fe-a0bd-56c300e76e7d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/908a0a18-6e21-4f3d-aeda-c9a27a61a9e7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/908a0a18-6e21-4f3d-aeda-c9a27a61a9e7_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84bf83be-7658-40f4-bafe-a01eaae439a8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"Family 3","estimatedLodScore":5.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/84bf83be-7658-40f4-bafe-a01eaae439a8","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/554765f2-87ab-476c-8d3f-19451ddd494f"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":21,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000556","obo:HP_0000529","obo:HP_0000543","obo:HP_0007843","obo:HP_0000550","obo:HP_0007737","obo:HP_0000007"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/554765f2-87ab-476c-8d3f-19451ddd494f"},"publishedLodScore":6.09,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ef61295d-c3d2-4eed-9b9e-e03a8c6ac104_proband_segregation","type":"FamilyCosegregation","dc:description":"LOD score was determined at the group level for all 3 families and therefor only included for a single family (family 3) in the final aggregate calculation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"Family 1","estimatedLodScore":2.66,"family":{"id":"https://genegraph.clinicalgenome.org/r/ef61295d-c3d2-4eed-9b9e-e03a8c6ac104","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f02a7ca0-ece0-44a6-a3ef-0fb401291f79"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000007","obo:HP_0000556","obo:HP_0000529","obo:HP_0000550","obo:HP_0000543","obo:HP_0007737","obo:HP_0007843"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f02a7ca0-ece0-44a6-a3ef-0fb401291f79"},"publishedLodScore":6.09},{"id":"https://genegraph.clinicalgenome.org/r/0b76a8aa-f5cb-4e97-b3ca-6e88c17910cc_proband_segregation","type":"FamilyCosegregation","dc:description":"LOD score was determined at the group level for all 3 families and therefor only included for a single family (family 3) in the final aggregate calculation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"Family 2","estimatedLodScore":2.58,"family":{"id":"https://genegraph.clinicalgenome.org/r/0b76a8aa-f5cb-4e97-b3ca-6e88c17910cc","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c6427459-25b5-4ff9-be2a-33909e632609"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":11,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000543","obo:HP_0000529","obo:HP_0000007","obo:HP_0007843","obo:HP_0000550","obo:HP_0007737","obo:HP_0000556"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c6427459-25b5-4ff9-be2a-33909e632609"},"publishedLodScore":6.09}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/137a1c9f-85e7-4fd1-a5be-105006af46ee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/137a1c9f-85e7-4fd1-a5be-105006af46ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","rdfs:label":"OGI1242-2406","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ec716a1d-fc63-4803-b4ed-526068e67fe3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.295C>A (p.Leu99Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252088"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000007","obo:HP_0000572","obo:HP_0000529","obo:HP_0007401","obo:HP_0007737","obo:HP_0000603","obo:HP_0000512"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/813dd9eb-1ed6-428e-befd-66801bde032f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32014858","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec716a1d-fc63-4803-b4ed-526068e67fe3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/813dd9eb-1ed6-428e-befd-66801bde032f","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/813dd9eb-1ed6-428e-befd-66801bde032f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/813dd9eb-1ed6-428e-befd-66801bde032f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID:16269441 Fig 3. RDH12 activity was assayed in cell lysates  under conditions in which retinoid reductase activity was time- and concentration-dependent, missense variant p.L99I showed dramatically reduced ability to convert all- trans retinal to all- trans retinol in the presence of NADPH ( P <0.001)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/076159c3-07c9-4f87-8349-6071f054e906_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/076159c3-07c9-4f87-8349-6071f054e906","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"828","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/722baf81-3142-477d-9687-3e377e1a4f53","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152443.3(RDH12):c.806_810del (p.Ala269fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339935"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000550","obo:HP_0000529","obo:HP_0007737","obo:HP_0000546"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/996ff6f1-e44e-4543-9209-92faf3bd20d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","allele":{"id":"https://genegraph.clinicalgenome.org/r/722baf81-3142-477d-9687-3e377e1a4f53"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/996ff6f1-e44e-4543-9209-92faf3bd20d8","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/996ff6f1-e44e-4543-9209-92faf3bd20d8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fa7375b-ac91-46d2-a2ba-5e3ffad989c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e4c31d6-21a7-4157-b403-cc8b5cd5ad8e","type":"Finding","dc:description":"In situ hybridization of RDH12 transcripts in monkey and mouse retina using antisense RNA show the localization in photoreceptor inner segments and cell bodies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12226107","rdfs:label":"In situ hybridization of monkey and mouse RDH12","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/40c4babb-3f89-4a66-a848-d60ce8a7ba74","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dad561a5-e86e-46db-8884-671aaf649d8b","type":"Finding","dc:description":"Cells expressing RDH12 were assayed for activity towards various retinoid isomers in the presence of NADH and NADPH. The products were analyzed by HPLC showing RDH12 catalyzed the reduction of all-trans-retinal and its 9-cis-, 11-cis-, and 13-cis-retinal isomers.  Figure 5, 6 A,C-D","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12226107","rdfs:label":"RDH activity with various isomers of retinal","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bd51db77-53c3-4f89-9a4c-c92bbe182d7e_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/386c4ab8-5e0c-49cb-a00d-58fc013c72fe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6549a37e-be06-47d8-a3a7-bc72171df34b","type":"FunctionalAlteration","dc:description":"Ability of RDH12 protein to catalyzed the conversion of all-trans retinal to all-trans retinol was assessed in cells transfected with wild type or variants. Lysates from cells expressing the Cys226 variant had no significant RDH12 activity in the forward or reverse reactions, consistent with a loss of function of RDH12. The Met49 variant had altered activity with an increase in conversion to all-trans retinol compared to wild-type protein and lowered in the reverse reaction as compared to wild type protein.  Western blot showed decrease in protein expression for Cys226 variant, and decreased expression of unglycosylated protein, but similar total levels in Met49 variant. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15258582","rdfs:label":"Expression and activity analysis in transfected COS-7 cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f6774b89-49c4-49b3-aa48-d000838a7676","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db2a6f55-0014-4d2a-8a1f-bea12acb1aee","type":"FunctionalAlteration","dc:description":"RDH12 activity was assayed in cell lysates using normal phase HPLC under conditions in which retinoid reductase activity was time- and concentration-dependent, missense variants\nshowed dramatically reduced ability to convert all-trans retinal to all-trans retinol in the presence of NADPH, exhibiting 5– 44% wild-type levels of activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16269441","rdfs:label":"In vitro functional analysis of RDH12 missense mutations"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":4791,"specifiedBy":"GeneValidityCriteria9","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tw-ROO19jas","type":"GeneValidityProposition","disease":"obo:MONDO_0800099","gene":"hgnc:19977","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bd51db77-53c3-4f89-9a4c-c92bbe182d7e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}